Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PF-04523655

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Age‐related macular degeneration (AMD) and glaucoma are global ocular diseases with high blindness rate. RNA interference (RNAi… Expand
2014
2014
PURPOSE The intraocular pharmacodynamics of PF-04523655, a small-interfering RNA (siRNA) directed against RTP801, was… Expand
Highly Cited
2012
Highly Cited
2012
PURPOSE To evaluate the safety and efficacy of three doses of PF-04523655, a 19-nucleotide methylated double stranded siRNA… Expand
Highly Cited
2012
Highly Cited
2012
OBJECTIVE To evaluate the efficacy of different dosing paradigms of PF-04523655 (PF) versus ranibizumab (comparator) in subjects… Expand
Highly Cited
2012
Highly Cited
2012
BackgroundTo evaluate the safety, tolerability, pharmacokinetics, and dose-limiting toxicities of a single intravitreal (IVT… Expand
  • table 1
  • figure 1
  • table 1
  • table 2
  • table 3